The Importance of Adrenomedullin (AM) on ACTH-Cortisol-Glucose Axis
NCT00459511 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2007-04-12
Summary
Hyperglycemia is frequent manifestations of the human metabolic response to systemic inflammatory response syndrome (SIRS),sepsis and septic shock, and are implicated in the clinical outcome.
Adrenomedullin is elevated in SIRS, sepsis and septic shock and has been demonstrated the inhibitory role on insulin and adrenocorticotropic hormone secretion.
Our hypothesis is that: AM elevation after SIRS could be the responsible to maintain hyperglycemia
Conditions
- Systemic Inflammatory Response Syndrome
- Hyperglycemia
Interventions
- PROCEDURE
-
Blood AM, IL-6, ACTH, Cortisol, Glucose and Insulin
Sponsors & Collaborators
-
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
collaborator OTHER_GOV -
University of Sao Paulo
lead OTHER
Principal Investigators
-
Thelma Okay, PHD · Childrens Institute / Molecular Biology
Eligibility
- Min Age
- 2 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Completion
- 2006-10-31
Countries
- Brazil
Study Locations
More Related Trials
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients
NCT07234526 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
NCT02654561 ·Status: RECRUITING ·Phase: PHASE3
-
Early Identification and Effective Management of Pediatric Sepsis
NCT03996720 ·Status: COMPLETED
-
Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
NCT02519699 ·Status: COMPLETED ·Phase: PHASE4
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Insulin Resistance in Stress-metabolic Medical Patients
NCT04239937 ·Status: UNKNOWN
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED
-
The Effect of Moderate-Dose Steroid Therapy in Sepsis
NCT01275638 ·Status: COMPLETED ·Phase: PHASE4
-
The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries
NCT01333657 ·Status: COMPLETED
-
Therapy With Hydrocortisone, Ascorbic Acid, Thamine in Patients With Sepsis
NCT04160676 ·Status: COMPLETED ·Phase: NA
-
Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic Shock
NCT00523198 ·Status: COMPLETED
-
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock
NCT00159952 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Septic Shock em Steroids
NCT01047670 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
IgM-enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis
NCT02444871 ·Status: COMPLETED
-
Early Resuscitation in Paediatric Sepsis Using Inotropes
NCT06478797 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Glycocalyx and Microcirculation in Sepsis
NCT03960307 ·Status: COMPLETED
-
Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis
NCT05640037 ·Status: COMPLETED
-
Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
NCT05451537 ·Status: UNKNOWN
-
Myeloid-derived Suppressor Cells in Sepsis
NCT03540797 ·Status: UNKNOWN
-
Increasing Insulin Resistance as a Predictor of Impending Bacteremia
NCT04992689 ·Status: COMPLETED
-
Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients
NCT02698683 ·Status: COMPLETED
-
Proadrenomedullin and Microcirculation in Monitoring Organ Dysfunction in Patient With Infection
NCT03931967 ·Status: COMPLETED
-
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
NCT04117568 ·Status: TERMINATED
-
GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia
NCT04569877 ·Status: COMPLETED ·Phase: PHASE2